Varicella Zoster Virus gpIII Inhibitors
Varicella Zoster Virus gpIII inhibitors target multiple biochemical and cellular pathways to inhibit the functionality or expression of the gpIII protein. Nucleoside analogs such as acyclovir and ganciclovir specifically inhibit viral DNA polymerase, effectively reducing DNA replication rates. This results in a limited transcription and translation of Varicella Zoster Virus gpIII, thereby affecting its role in viral assembly. Similarly, foscarnet also acts on viral DNA and RNA polymerases, as well as HIV reverse transcriptase, to achieve the same result. Leflunomide, on the other hand, hampers pyrimidine synthesis by inhibiting dihydroorotate dehydrogenase. This enzymatic blockade affects not just DNA replication but also RNA synthesis, affecting both transcription and translation of Varicella Zoster Virus gpIII.
Another class of inhibitors acts on nucleotide biosynthesis pathways. For instance, ribavirin targets IMP dehydrogenase, which is crucial for purine nucleotide biosynthesis, thereby disrupting viral RNA and DNA synthesis. Mycophenolic acid also targets the same enzyme but disrupts both purine and pyrimidine nucleotide biosynthesis. This dual action imposes a more comprehensive blockade on the transcription and translation of Varicella Zoster Virus gpIII. In contrast, amenamevir interferes with the helicase-primase complex, affecting the unwinding of DNA and thus affecting the DNA replication processes crucial for Varicella Zoster Virus gpIII expression. Baloxavir Marboxil uniquely targets the 'cap-snatching' mechanism, vital for viral mRNA synthesis, by inhibiting the endonuclease activity of the viral PA protein
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Ganciclovir | 82410-32-0 | sc-203963 sc-203963A | 50 mg 250 mg | $233.00 $421.00 | 1 | |
Targets viral DNA polymerase and halts DNA chain elongation, which affects the transcription and eventual translation of Varicella Zoster Virus gpIII. | ||||||
Foscarnet sodium | 63585-09-1 | sc-205330 sc-205330A | 1 g 5 g | $190.00 $676.00 | ||
Inhibits viral DNA and RNA polymerases as well as HIV reverse transcriptase. This affects the overall transcription and translation rates of Varicella Zoster Virus gpIII. | ||||||
Brivudine | 69304-47-8 | sc-205607 sc-205607A sc-205607B sc-205607C | 10 mg 25 mg 100 mg 1 g | $224.00 $469.00 $1020.00 $2142.00 | 4 | |
Inhibits thymidine kinase, an enzyme that phosphorylates nucleosides for DNA synthesis, thus affecting the availability of Varicella Zoster Virus gpIII by limiting its transcription. | ||||||
Penciclovir | 39809-25-1 | sc-203183 | 100 mg | $260.00 | ||
Acts on viral DNA polymerase, thereby inhibiting viral DNA replication and affecting the levels of Varicella Zoster Virus gpIII. | ||||||
Valacyclovir Hydrochloride | 124832-27-5 | sc-204937 sc-204937A | 50 mg 100 mg | $119.00 $153.00 | ||
A prodrug that is metabolized into acyclovir in vivo. The resulting acyclovir inhibits viral DNA polymerase, decreasing the availability of Varicella Zoster Virus gpIII. | ||||||
Leflunomide | 75706-12-6 | sc-202209 sc-202209A | 10 mg 50 mg | $20.00 $83.00 | 5 | |
Inhibits dihydroorotate dehydrogenase, an enzyme involved in pyrimidine synthesis. This hampers viral DNA replication and, consequently, the transcription and translation of Varicella Zoster Virus gpIII. | ||||||
Ribavirin | 36791-04-5 | sc-203238 sc-203238A sc-203238B | 10 mg 100 mg 5 g | $63.00 $110.00 $214.00 | 1 | |
Inhibits IMP dehydrogenase, affecting purine nucleotide biosynthesis, which disrupts viral RNA and DNA synthesis and thus downregulates Varicella Zoster Virus gpIII. | ||||||
Mycophenolic acid | 24280-93-1 | sc-200110 sc-200110A | 100 mg 500 mg | $69.00 $266.00 | 8 | |
Inhibits inosine monophosphate dehydrogenase, disrupting both purine and pyrimidine synthesis, affecting the production of Varicella Zoster Virus gpIII by limiting its transcription. | ||||||
Cidofovir | 113852-37-2 | sc-482141 | 50 mg | $135.00 | ||
Targets viral DNA polymerase, and its activity leads to chain termination, thus impeding the transcription and translation of Varicella Zoster Virus gpIII. | ||||||
Baloxavir marboxil | 1985606-14-1 | sc-507295 | 100 mg | $132.00 | ||
Targets the endonuclease activity of the viral polymerase acidic (PA) protein, which inhibits the 'cap-snatching' mechanism necessary for viral mRNA synthesis. Consequently, this disrupts the synthesis and function of Varicella Zoster Virus gpIII. | ||||||